| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology, and Genetics |
Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland
Requests for reprints: Linda A. Lee, 720 Rutland Avenue, Ross, 1029, Baltimore, MD 21205. Phone: 410-502-5058; Fax: 410-955-0185; E-mail: llee12{at}jhmi.edu.
The oncogene c-myc encodes a transcription factor that has long been considered essential to liver regeneration, the process by which fully differentiated hepatocytes proliferate in an attempt to maintain a normal functional mass in response to hepatic injury. Experimental liver regeneration can be induced upon 70% partial hepatectomy and is accompanied by an increase in c-myc expression accompanying the synchronous entry of remaining hepatocytes into the cell cycle. Because liver regeneration is an essential process for achieving liver homeostasis, therapies directed at reducing MYC expression in hepatocellular carcinoma are fraught with the theoretical possibility of injuring adjacent noncancerous liver cells, thereby restricting the liver's normal regenerative response to injury. To determine if intact c-myc is required for liver regeneration, we reduced hepatic c-myc in c-mycfl/fl mice using an adenoviral vector that expresses Cre recombinase. Despite a 90% decrease in hepatic expression of c-myc, restoration of liver mass 7 days later was not compromised. Reconstituted liver retained the same decrease in hepatic c-myc, indicating that hepatocytes deficient in c-myc were able to proliferate in response to partial hepatectomy. Although c-myc is required for embryonic development, our findings indicate that it is not required for the maintenance of the adult liver. (Cancer Res 2006; 66(11): 5608-12)
This article has been cited by other articles:
|
|
 |
|
  E. Mendieta-Condado, M. Pichardo-Olvera, L. Sanchez-Sevilla, V. Chagoya de Sanchez, and R. Hernandez-Munoz Adenosine Administration Accelerates Progression of the Cell Cycle during Rat Liver Regeneration Induced by One-Third Hepatectomy J. Pharmacol. Exp. Ther., October 1, 2009; 331(1): 122 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Reed, D. Athineos, V. S. Meniel, J. A. Wilkins, R. A. Ridgway, Z. D. Burke, V. Muncan, A. R. Clarke, and O. J. Sansom B-catenin deficiency, but not Myc deletion, suppresses the immediate phenotypes of APC loss in the liver PNAS, December 2, 2008; 105(48): 18919 - 18923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Chopra, J.-F. Louet, P. Saha, J. An, F. DeMayo, J. Xu, B. York, S. Karpen, M. Finegold, D. Moore, et al. Absence of the SRC-2 Coactivator Results in a Glycogenopathy Resembling Von Gierke's Disease Science, November 28, 2008; 322(5906): 1395 - 1399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Ho, C. E. Bass, A. H. K. Kroemer, C. Ma, E. Terwilliger, and S. J. Karp Optimized adeno-associated virus 8 produces hepatocyte-specific Cre-mediated recombination without toxicity or affecting liver regeneration Am J Physiol Gastrointest Liver Physiol, August 1, 2008; 295(2): G412 - G419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. He, H. Hu, R. Braren, S.-Y. Fong, A. Trumpp, T. R. Carlson, and R. A. Wang c-myc in the hematopoietic lineage is crucial for its angiogenic function in the mouse embryo Development, July 15, 2008; 135(14): 2467 - 2477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Wilkins and O. J. Sansom C-Myc Is a Critical Mediator of the Phenotypes of Apc Loss in the Intestine Cancer Res., July 1, 2008; 68(13): 4963 - 4966. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
